Scarpa Joseph
Department of Anesthesiology, Weill Cornell Medicine, New York, New York, USA.
Curr Opin Organ Transplant. 2023 Dec 1;28(6):412-418. doi: 10.1097/MOT.0000000000001100. Epub 2023 Sep 29.
Molecular omics data is increasingly ubiquitous throughout medicine. In organ transplantation, recent large-scale research efforts are generating the 'transplant-ome' - the entire set of molecular omics data, including the genome, transcriptome, proteome, and metabolome. Importantly, early studies in anesthesiology have demonstrated how perioperative interventions alter molecular profiles in various patient populations. The next step for anesthesiologists and intensivists will be to tailor perioperative care to the transplant-ome of individual liver transplant patients.
In liver transplant patients, elements of the transplant-ome predict complications and point to novel interventions. Importantly, molecular profiles of both the donor organ and recipient contribute to this risk, and interventions like normothermic machine perfusion influence these profiles. As we can now measure various omics molecules simultaneously, we can begin to understand how these molecules interact to form molecular networks and emerging technologies offer noninvasive and continuous ways to measure these networks throughout the perioperative period. Molecules that regulate these networks are likely mediators of complications and actionable clinical targets throughout the perioperative period.
The transplant-ome can be used to tailor perioperative care to the individual liver transplant patient. Monitoring molecular networks continuously and noninvasively would provide new opportunities to optimize perioperative management.
分子组学数据在医学领域日益普遍。在器官移植中,近期的大规模研究工作正在生成“移植组”——包括基因组、转录组、蛋白质组和代谢组在内的整套分子组学数据。重要的是,麻醉学领域的早期研究已证明围手术期干预如何改变不同患者群体的分子特征。麻醉医生和重症监护医生的下一步工作将是根据个体肝移植患者的移植组来调整围手术期护理。
在肝移植患者中,移植组的要素可预测并发症并指向新的干预措施。重要的是,供体器官和受体的分子特征均会导致这种风险,而常温机器灌注等干预措施会影响这些特征。由于我们现在能够同时测量各种组学分子,我们可以开始了解这些分子如何相互作用形成分子网络,并且新兴技术提供了在围手术期对这些网络进行无创和连续测量的方法。调节这些网络的分子可能是围手术期并发症的介质和可采取行动的临床靶点。
移植组可用于为个体肝移植患者量身定制围手术期护理。持续且无创地监测分子网络将为优化围手术期管理提供新机会。